{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023344","form_type":"8-K","ticker":"PRPH","cik":"0000868278","company_name":"ProPhase Labs, Inc.","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.527270+00:00","generated_at":"2026-05-17T14:08:30.898219+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ProPhase Labs Q2 net loss narrows to $4.5M, gross margin turns positive; patent for BE-Smart; crypto treasury approved","bullets":["Q2 revenue $1.2M vs $1.5M YoY; net loss from continuing ops $4.5M ($0.11/share) vs $5.5M ($0.29/share).","Gross margin improved to 58.9% from (10.3)% YoY; operating expenses cut 35% YTD; sale of PMI generated $8.7M gain.","U.S. patent granted for BE-Smart esophageal adenocarcinoma test in August 2025; accelerates commercialization.","Board approved crypto treasury strategy including Bitcoin; proposed authorized share increase to 1 billion for flexibility.","Stockholders' equity rose to $11.5M (from $7.4M at year-end); cash $169K; Crown Medical estimates $50M recovery."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023344","json":"https://secwatch.observer/filing/0001641172-25-023344.json","markdown":"https://secwatch.observer/filing/0001641172-25-023344.md","text":"https://secwatch.observer/filing/0001641172-25-023344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/868278/000164117225023344/0001641172-25-023344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/868278/000164117225023344/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:08:30.898219+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}